ARCUTIS BIOTHERAPEUTICS
Arcutis Biotherapeutics is a privately held clinical-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company was founded in 2016 and is based in Westlake Village, California.
ARCUTIS BIOTHERAPEUTICS
Industry:
Biopharma Biotechnology Health Diagnostics Pharmaceutical Therapeutics
Founded:
2016-01-06
Address:
Westlake Village, California, United States
Country:
United States
Website Url:
http://www.arcutis.com
Total Employee:
251+
Status:
Active
Contact:
805-418-5006
Email Addresses:
[email protected]
Total Funding:
833.5 M USD
Technology used in webpage:
Domain Not Resolving CrUX Top 50m ReCAPTCHA V2 JQuery CDN Microsoft COVID-19 Microsoft Azure Mobile Optimized AddThis Akamai Hosted
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-09-08 | Ducentis BioTherapeutics | Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics | 400 M USD |
Investors List
SLR Capital Partners
SLR Capital Partners investment in Post-IPO Debt - Arcutis Biotherapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Arcutis Biotherapeutics
HBM Healthcare Investments
HBM Healthcare Investments investment in Series C - Arcutis Biotherapeutics
RA Capital Management
RA Capital Management investment in Series C - Arcutis Biotherapeutics
BlackRock
BlackRock investment in Series C - Arcutis Biotherapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series C - Arcutis Biotherapeutics
Goldman Sachs
Goldman Sachs investment in Series C - Arcutis Biotherapeutics
Omega Funds
Omega Funds investment in Series C - Arcutis Biotherapeutics
OrbiMed
OrbiMed investment in Series C - Arcutis Biotherapeutics
Bain Capital
Bain Capital investment in Series C - Arcutis Biotherapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2023-09-27 | Arcutis Appoints L. Todd Edwards as Chief Commercial Officer |
Official Site Inspections
http://www.arcutis.com Semrush global rank: 2.42 M Semrush visits lastest month: 7.85 K
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Arcutis Biotherapeutics"
Medical dermatology innovation | Arcutis Biotherapeutics
At Arcutis, meaningful innovation means focusing on unmet needs in the treatment of immune-mediated skin diseases. With extensive medical dermatology development expertise and a unique dermatology drug …See details»
About Us - Arcutis Biotherapeutics
A career at Arcutis is an opportunity for growth at an exciting and innovative biotherapeutics company committed to making a difference in the lives of patients and their families. At Arcutis, your passion for medical dermatology and …See details»
Meaningful innovation - Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc. 3027 Townsgate Road, Suite 300 Westlake Village, CA 91361 For more information, visit arcutis.ca Corporate contact : [email protected] 1-833-427-2884 …See details»
Corporate Overview - Arcutis Biotherapeutics
Arcutis Biotherapeutics - Crunchbase Company Profile …
Arcutis Biotherapeutics reported significant revenue growth in Q4 2023 and beat expectations for its full-year 2023 earnings. Analysts have upgraded their revenue forecasts for the company, and Mizuho has lifted its share target based on a …See details»
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) | LinkedIn
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is an early commercial stage biopharmaceutical company focused on developing and ...See details»
Our Approach to Clinical Trials - About Us - Arcutis …
Arcutis strives to enrol a diverse population in our clinical trials in order to more accurately characterize how new treatments perform in different groups. ... Our commitment to Diversity & Inclusion spans all levels of our organization …See details»
Arcutis Biotherapeutics Medical Affairs | Bioscience applied to the …
Arcutis is focused on filling the innovation gap in medical dermatology drug development. The information contained in this website has been developed by Arcutis Medical Affairs and is …See details»
Arcutis Announces Third Quarter 2024 Financial Results and …
Nov 6, 2024 Arcutis’ dermatology development platform includes a robust pipeline with multiple clinical programs for a range of inflammatory dermatological conditions including scalp and …See details»
Arcutis Announces Updates to its Executive Team
Mar 26, 2021 Prior to joining Arcutis, Mr. Padovano was at Gilead Sciences, where he held roles of increasing responsibility, culminating in the role of Executive Director, Marketing …See details»
Arcutis Announces First Quarter 2023 Financial Results and …
May 9, 2023 The Company has built an experienced commercial and medical organization in Canada in preparation of the launch for plaque psoriasis, and to support the continued …See details»
Meaningful innovation - Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc. 3027 Townsgate Road, Suite 300 Westlake Village, CA 91361 Corporate contact : [email protected] 805-418-5006 Media and investor contact : …See details»
Arcutis Biotherapeutics, Inc. (ARQT) - Yahoo Finance
Find the latest Arcutis Biotherapeutics, Inc. (ARQT) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Arcutis Announces Additions to its Investor Relations and ...
Aug 2, 2021 Eric McIntyre joins as Head of Investor Relations; Amanda Sheldon joins as Head of Corporate Communications; WESTLAKE VILLAGE, Calif., Aug. 02, 2021 (GLOBE …See details»
Arcutis Biotherapeutics - Fortune
Arcutis Biotherapeutics is an empowered team looking at the inclusiveness and engagement across the company—it's a real differentiator and allows anyone in the company to get …See details»
Arcutis Announces Leadership Transition
May 24, 2023 We are grateful for his leadership and dedication as he built our commercial organization, launched ZORYVE in plaque psoriasis, and prepared us for future potential …See details»
Arcutis Biotherapeutics: Resilient Performance and Growth …
6 days ago Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque …See details»
Our Approach to Clinical Trials - Arcutis Biotherapeutics
Arcutis strives to enroll a diverse population in our clinical trials in order to more accurately characterize how new treatments perform in different groups. ... Our commitment to Diversity …See details»
Arcutis Announces Second Quarter 2022 Financial Results and …
Aug 4, 2022 “The FDA approval of ZORYVE for the treatment of plaque psoriasis is a pivotal milestone for the Arcutis organization, and for dermatologists and people suffering from …See details»
Does Arcutis Biotherapeutics (ARQT) Have the Potential to
4 days ago Shares of Arcutis Biotherapeutics, Inc. (ARQT) have gained 34.5% over the past four weeks to close the last trading session at $11.51, but there could still be a solid upside left in …See details»